These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10382877)

  • 41. Pharmacokinetics of moxifloxacin in plasma and tissue of morbidly obese patients.
    Kees MG; Weber S; Kees F; Horbach T
    J Antimicrob Chemother; 2011 Oct; 66(10):2330-5. PubMed ID: 21729931
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Disposition and metabolism of [14C]-haloperidol in rats.
    Miyazaki H; Matsunaga Y; Nambu K; Oh-e Y; Yoshida K; Hashimoto M
    Arzneimittelforschung; 1986 Mar; 36(3):443-52. PubMed ID: 3707663
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aqueous penetration and biological activity of moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution in cataract surgery patients.
    Kim DH; Stark WJ; O'Brien TP; Dick JD
    Ophthalmology; 2005 Nov; 112(11):1992-6. PubMed ID: 16183125
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Profile of moxifloxacin drug interactions.
    Stass H; Kubitza D
    Clin Infect Dis; 2001 Mar; 32 Suppl 1():S47-50. PubMed ID: 11249829
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics and bioavailability of moxifloxacin in calves following different routes of administrations.
    Goudah A; Hasabelnaby S
    Chemotherapy; 2010; 56(1):26-31. PubMed ID: 20197659
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of dairy products on the oral bioavailability of moxifloxacin, a novel 8-methoxyfluoroquinolone, in healthy volunteers.
    Stass H; Kubitza D
    Clin Pharmacokinet; 2001; 40 Suppl 1():33-8. PubMed ID: 11352440
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 2nd communication: tissue distribution and whole-body autoradiography of imidapril in rats.
    Yamada Y; Endo M; Kohno M; Otsuka M; Takaiti O
    Arzneimittelforschung; 1992 Apr; 42(4):466-74. PubMed ID: 1642669
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics of Nimodipine. II. Communication: distribution, elimination and placental transfer in rats following single and multiple doses of [14C]nimodipine.
    Suwelack D; Weber H; Maruhn D
    Arzneimittelforschung; 1985; 35(12):1787-94. PubMed ID: 4096730
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Penetration and accumulation of moxifloxacin in uterine tissue.
    Stass H; Kubitza D; Aydeniz B; Wallwiener D; Halabi A; Gleiter C
    Int J Gynaecol Obstet; 2008 Aug; 102(2):132-6. PubMed ID: 18501909
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of calcium supplements on the oral bioavailability of moxifloxacin in healthy male volunteers.
    Stass H; Wandel C; Delesen H; Möller JG
    Clin Pharmacokinet; 2001; 40 Suppl 1():27-32. PubMed ID: 11352439
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of food on the pharmacokinetics of a single oral dose of moxifloxacin 400mg in healthy male volunteers.
    Lettieri J; Vargas R; Agarwal V; Liu P
    Clin Pharmacokinet; 2001; 40 Suppl 1():19-25. PubMed ID: 11352438
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Absolute bioavailability of moxifloxacin.
    Ballow C; Lettieri J; Agarwal V; Liu P; Stass H; Sullivan JT
    Clin Ther; 1999 Mar; 21(3):513-22. PubMed ID: 10321420
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Concentrations of moxifloxacin in serum and pulmonary compartments following a single 400 mg oral dose in patients undergoing fibre-optic bronchoscopy.
    Soman A; Honeybourne D; Andrews J; Jevons G; Wise R
    J Antimicrob Chemother; 1999 Dec; 44(6):835-8. PubMed ID: 10590288
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Trans-epithelial intestinal elimination of moxifloxacin in rabbits.
    Musafija A; Ramon J; Shtelman Y; Yoseph G; Rubinovitz B; Segev S; Rubinstein E
    J Antimicrob Chemother; 2000 Jun; 45(6):803-5. PubMed ID: 10837433
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics and tissue distribution of ketanserin in rat, rabbit and dog.
    Michiels M; Monbaliu J; Meuldermans W; Hendriks R; Geerts R; Woestenborghs R; Heykants J
    Arzneimittelforschung; 1988 Jun; 38(6):775-84. PubMed ID: 3178917
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessment of chronic toxicity and carcinogenicity in an accelerated cancer bioassay in rats of moxifloxacin, a quinolone antibiotic.
    Iatropoulos MJ; Jeffrey AM; Enzmann HG; von Keutz E; Schlueter G; Williams GM
    Exp Toxicol Pathol; 2001 Oct; 53(5):345-57. PubMed ID: 11817103
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics of nisoldipine. II. Distribution to and elimination from tissues and organs following single or repeated administration of [14C]nisoldipine to rats and dogs.
    Ahr HJ; Krause HP; Suwelack D; Weber H
    Arzneimittelforschung; 1988 Aug; 38(8):1099-104. PubMed ID: 3196403
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preclinical safety evaluation of moxifloxacin, a novel fluoroquinolone.
    von Keutz E; Schlüter G
    J Antimicrob Chemother; 1999 May; 43 Suppl B():91-100. PubMed ID: 10382881
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics of latanoprost in the cynomolgus monkey. 3rd communication: tissue distribution after topical administration on the eye studied by whole body autoradiography. Glaucoma Research Laboratories.
    Sjöquist B; Johansson A; Stjernschantz J
    Arzneimittelforschung; 1999 Mar; 49(3):240-9. PubMed ID: 10219468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.